You are here

biosimilars

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal

Fierce Pharma

Wed, 05/10/23 - 10:00 am

As Humira biosims take hold, longtime AbbVie CEO Richard Gonzalez talks succession plans

Fierce Pharma

Thu, 04/27/23 - 11:02 pm

Richard Gonzalez

Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA

Business Insider

Mon, 04/17/23 - 11:06 pm

Teva Pharmaceutical

FDA rejects Teva’s high-potency biosimilar of Humira again

Pharmaphorum

Fri, 04/14/23 - 10:37 am

Teva Pharmaceutical

Amgen's denosumab shows promise in small, NIH-funded rare bone disease study

Endpoints

Wed, 04/5/23 - 07:15 pm

clinical trials

monoclonal antibodies

Acquired patents aid J&J defense of top-selling drug from biosimilar challenge

BioPharma Dive

Wed, 03/29/23 - 03:56 pm

J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest

Endpoints

Mon, 03/20/23 - 09:50 am

Sandoz, betting on biosimilar sales, to build new production plant

BioPharma Dive

Thu, 03/9/23 - 09:15 pm

drug manufacturing

Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim

Fierce Pharma

Fri, 03/3/23 - 11:56 am

Could This Humira Biosimilar Be a Winner for Amgen?

Motley Fool

Fri, 03/3/23 - 11:48 am

Doctors largely comfortable with biosimilar drugs, but question economics: report

BioPharma Dive

Wed, 02/22/23 - 06:49 pm

Cardinal Health

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

BioPharma Dive

Tue, 02/21/23 - 11:05 am

Bristol Myers Squibb

Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US

Pharmaceutical Business Review

Fri, 02/17/23 - 09:44 am

Years after the first US biosim launches, doctors still have their concerns: survey

Fierce Pharma

Thu, 02/16/23 - 04:49 pm

FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks

Endpoints

Mon, 02/13/23 - 10:02 pm

drug manufacturing

AbbVie talks next steps as first Humira competitor makes it to market

Endpoints

Thu, 02/9/23 - 06:01 pm

Sandoz files biosimilar of Amgen osteoporosis drug in US

Pharmaphorum

Tue, 02/7/23 - 12:22 pm

Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita

Forbes

Wed, 02/1/23 - 10:41 am

Amgen launches Humira biosimilar, releases Q4 earnings report

Medical Marketing and Media

Tue, 01/31/23 - 11:21 pm

Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug

BioPharma Dive

Tue, 01/31/23 - 12:37 pm

Pages